| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized, double-blind, placebo-controlled phase III study evaluating the preventive effect of diclofenac cream on capecitabine-related hand-foot syndrome: study protocol of J-SUPPORT2401/JORTC-SUP06 (J-DIRECT)
|
Iimura, Yohei
|
|
|
30 |
8 |
p. 1553-1561
|
artikel
|
| 2 |
Collaborative frontiers in pediatric neuro-oncology: establishing an international tumor board for enhanced care and global impact
|
Shatara, Margaret
|
|
|
30 |
8 |
p. 1659-1669
|
artikel
|
| 3 |
Current advances and challenges in minimally invasive esophagectomy
|
Booka, Eisuke
|
|
|
30 |
8 |
p. 1463-1474
|
artikel
|
| 4 |
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trial
|
Izutsu, Koji
|
|
|
30 |
8 |
p. 1631-1640
|
artikel
|
| 5 |
Escalation and de-escalation in surgery for gastric cancer
|
Ichikawa, Daisuke
|
|
|
30 |
8 |
p. 1475-1483
|
artikel
|
| 6 |
Impact of body mass index on D-dimer diagnostic utility for deep vein thrombosis in patients with cancer: a single-center retrospective analysis
|
Masuda, Yuya
|
|
|
30 |
8 |
p. 1545-1552
|
artikel
|
| 7 |
Impact of cancer type differences on chemotherapy-induced nausea and vomiting (CINV) incidence in oxaliplatin-based regimens for gastric and colorectal cancer: a retrospective study
|
Hiraga, Nanaho
|
|
|
30 |
8 |
p. 1602-1609
|
artikel
|
| 8 |
Impact of medications on the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic head and neck cancer
|
Minohara, Kiyoshi
|
|
|
30 |
8 |
p. 1572-1581
|
artikel
|
| 9 |
Impact of second-line combination chemotherapy on post-progression survival in metastatic and recurrent pancreatic cancer
|
Mie, Takafumi
|
|
|
30 |
8 |
p. 1610-1620
|
artikel
|
| 10 |
LH–RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study
|
Kishida, Takuma
|
|
|
30 |
8 |
p. 1562-1571
|
artikel
|
| 11 |
Narrative review of focal boost to intraprostatic dominant lesion in intensity-modulated radiation therapy for localized or locally advanced prostate cancer
|
Aizawa, Rihito
|
|
|
30 |
8 |
p. 1448-1462
|
artikel
|
| 12 |
Palliative radiotherapy for bone metastases: conventional external beam radiotherapy
|
Kibe, Yuichi
|
|
|
30 |
8 |
p. 1484-1491
|
artikel
|
| 13 |
Palliative radiotherapy for painful non-bone-metastasis tumors
|
Saito, Tetsuo
|
|
|
30 |
8 |
p. 1500-1504
|
artikel
|
| 14 |
Palliative stereotactic body radiotherapy for spinal and non-spinal bone metastases: combining tradition and innovation
|
Ito, Kei
|
|
|
30 |
8 |
p. 1492-1499
|
artikel
|
| 15 |
Percutaneous cryoablation versus robot-assisted partial nephrectomy for small renal cell carcinoma: a retrospective cost analysis at Japanese single-institution
|
Uka, Mayu
|
|
|
30 |
8 |
p. 1621-1630
|
artikel
|
| 16 |
Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors
|
Kubo, Toshio
|
|
|
30 |
8 |
p. 1537-1544
|
artikel
|
| 17 |
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumors
|
Muro, Kei
|
|
|
30 |
8 |
p. 1522-1536
|
artikel
|
| 18 |
Physical activity and cancer biology: a narrative review of molecular mechanisms and introduction of the SCRUM-MONSTAR LIFELOG study
|
Yajima, Shugo
|
|
|
30 |
8 |
p. 1439-1447
|
artikel
|
| 19 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of belantamab mafodotin for multiple myeloma, asciminib for leukemia, osimertinib for lung cancer, amivantamab for lung cancer, and pembrolizumab for pleural mesothelioma in Japan
|
Matsumura, Noriomi
|
|
|
30 |
8 |
p. 1437-1438
|
artikel
|
| 20 |
Potassium-competitive acid blocker has more negative impacts on clinical outcomes in patients with non-small cell lung cancer treated with checkpoint inhibitors than those of proton pump inhibitors
|
Takahashi, Masaya
|
|
|
30 |
8 |
p. 1582-1592
|
artikel
|
| 21 |
Prognostic factors and the impact of neoadjuvant chemotherapy on the development of metastasis in patients with undifferentiated pleomorphic sarcoma of soft tissue
|
Miwa, Shinji
|
|
|
30 |
8 |
p. 1650-1658
|
artikel
|
| 22 |
Risk factors for early mortality among patients with gastrointestinal malignancy in the C-CAT database
|
Suzuki, Rei
|
|
|
30 |
8 |
p. 1593-1601
|
artikel
|
| 23 |
Stereotactic body radiotherapy for oligometastatic disease: current evidence and future perspectives
|
Imano, Nobuki
|
|
|
30 |
8 |
p. 1505-1521
|
artikel
|
| 24 |
Systematic review and meta-analysis of photon radiotherapy versus proton beam therapy for pediatric rhabdomyosarcoma: TRP-rhabdomyosarcoma 2024
|
Fukushima, Hiroko
|
|
|
30 |
8 |
p. 1670-1677
|
artikel
|
| 25 |
The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma
|
Matsui, Yoshiyuki
|
|
|
30 |
8 |
p. 1641-1649
|
artikel
|
Tijdschrift beschrijving